Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rabbit complement lyses tumor cells without massive C3 deposition

G L Ong1, P B Shah, M J Mattes

  • 1Center for Molecular Medicine and Immunology, Newark, NJ 07103, USA.

Immunological Investigations
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-principles investigation of oxidized Si- and Ge-terminated diamond (100) surfaces.

The Journal of chemical physics·2024
Same author

APOL1 Polymorphisms in a Deceased Donor and Early Presentation of Collapsing Glomerulopathy and Focal Segmental Glomerulosclerosis in Two Recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Apoptosis assays with lymphoma cell lines: problems and pitfalls.

British journal of cancer·2007
Same author

Antibodies to CD20 and MHC class II antigen bound to B-lymphoma cells accumulate in shed cytoplasmic fragments.

British journal of cancer·2004
Same author

Assessment of colour vision as a screening test for sight threatening diabetic retinopathy before loss of vision.

The British journal of ophthalmology·2003
Same author

Chromatic contrast thresholds as a prognostic test for visual improvement after macular hole surgery: color vision and macular hole surgery outcome.

Retina (Philadelphia, Pa.)·2002
Same journal

The Emerging Role of Tumor-Associated Neutrophils in Modulating Immune Checkpoint Inhibitor Response and Therapeutic Strategies.

Immunological investigations·2026
Same journal

Immune Reconstitution After Hematopoietic Stem Cell Transplantation: Cellular Dynamics, Clinical Determinants, and Emerging Therapeutic Strategies.

Immunological investigations·2026
Same journal

Riboflavin Modulates Complement Activation, Immune Cell Viability and Activation, and Neutrophil Microbicidal Functions <i>in Vitro</i>.

Immunological investigations·2026
Same journal

Pharmacological Modulation of Immunosenescence and Inflammaging: Senolytics, Senomorphics, and Emerging Therapies.

Immunological investigations·2026
Same journal

Nanoantibodies: A Review of Diagnostic and Therapeutic Applications in Respiratory Diseases.

Immunological investigations·2026
Same journal

TRIM31: A Novel Guardian Against Periodontal Inflammation via Modulation of NLRP3 Inflammasome and Macrophage Polarization.

Immunological investigations·2026
See all related articles

Rabbit complement efficiently lyses antibody-coated human tumor cells, unlike other species. This potent tumor cell lysis by rabbit complement occurs despite minimal complement component 3 (C3) deposition, suggesting a unique mechanism.

Area of Science:

  • Immunology
  • Complement System
  • Cancer Research

Background:

  • The complement system is crucial in innate and adaptive immunity, mediating pathogen lysis and immune cell activation.
  • Rabbit complement exhibits potent lysis of antibody-coated tumor cells, a phenomenon not observed in other species' complement activity.
  • Understanding species-specific differences in complement function is vital for therapeutic applications, particularly in cancer immunotherapy.

Purpose of the Study:

  • To investigate the mechanism behind the high efficiency of rabbit complement in lysing antibody-coated human tumor cells.
  • To compare rabbit complement activity with that of five other mammalian species in tumor cell lysis assays.
  • To elucidate the role of complement component 3 (C3) deposition in the observed cytotoxic effects.

Main Methods:

Related Experiment Videos

  • Tumor cell lysis assays using human tumor cells coated with mouse IgG(2a) monoclonal antibodies.
  • Complement-mediated cytotoxicity testing with serum from five mammalian species (human, guinea pig, rat, mouse, rabbit).
  • Quantification of C3 deposition on target cells using radiolabeled anti-C3 antibodies.

Main Results:

  • Rabbit complement demonstrated potent lysis of target tumor cells at low antibody concentrations.
  • Complement from human, rat, guinea pig, and mouse deposited significantly higher amounts of C3 (100-1,000 fold more) than rabbit complement.
  • A potential inverse correlation between C3 deposition and cytotoxic activity was observed, challenging conventional understanding of complement function.

Conclusions:

  • Rabbit complement possesses a unique and potent mechanism for lysing antibody-coated tumor cells, distinct from other tested species.
  • The high cytotoxic efficacy of rabbit complement is not directly correlated with C3 deposition, suggesting alternative complement pathway activation or effector mechanisms.
  • Fundamental differences in the complement cascade exist between rabbits and other mammals, warranting further investigation into the underlying molecular mechanisms.